1,645
Views
5
CrossRef citations to date
0
Altmetric
Short Report

Fourteen years’ clinical experience and the first million babies protected with human live-attenuated vaccine against rotavirus disease in Italy

ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon, & ORCID Icon show all
Pages 4636-4645 | Received 25 May 2021, Accepted 07 Jul 2021, Published online: 09 Aug 2021

References

  • Bartolozzi G. I vaccini contro i rotavirus (Vaccines against rotavirus). Area Pediatrica. 2011;12:1–9.
  • Pellegrinelli L, Bubba L, Primache V, Chiaramonte I, Ruggeri FM, Fiore L, Binda S. Burden of pediatrics hospitalizations associated with rotavirus gastroenteritis in Lombardy (Northern Italy) before immunization program. Ann Ist Super Sanita. 2015;51:346–51. doi:10.4415/ann_15_04_16.
  • Saia M, Giliberti A, Callegaro G, Baldovin T, Busana MC, Pietrobon F, Bertoncello C, Baldo V. Hospitalisation for rotavirus gastroenteritis in the paediatric population in the Veneto Region, Italy. BMC Public Health. 2010;10:636. doi:10.1186/1471-2458-10-636.
  • Festini F, Cocchi P, Mambretti D, Tagliabue B, Carotti M, Ciofi D, Biermann KP, Schiatti R, Ruggeri FM, De Benedictis FM, et al. Nosocomial rotavirus gastroenteritis in pediatric patients: a multi-center prospective cohort study. BMC Infect Dis. 2010;10:235. doi:10.1186/1471-2334-10-235.
  • Mattei A, Sbarbati M, Fiasca F, Angelone AM, Mazzei MC, di Orio F. Temporal trends in hospitalization for rotavirus gastroenteritis: a nationwide study in Italy, 2005–2012. Hum Vaccin Immunother. 2016;12(2):534–39. doi:10.1080/21645515.2015.1081726.
  • Marocco A, Assael B, Gabutti G, Guarino A, Lopalco PL, Marchetti F, Ruggeri FM, Titone L, Tozzi AE, Vitali Rosati G, et al. [Hospitalisation associated with rotavirus gastroenteritis in Italy, 2001-2003, evaluated by means of ICD9-CM diagnostic codes]. Ig Sanita Pubbl. 2006;62:215–44.
  • Ansaldi F, Lai P, Valle L, Riente R, Durando P, Sticchi L, Tucci P, Biasci P, Crovari P, Gasparini R, et al. Burden of rotavirus-associated and non-rotavirus-associated diarrhea among nonhospitalized individuals in central Italy: a 1-year sentinel-based epidemiological and virological surveillance. Clin Infect Dis. 2008;46(6):e51–55. doi:10.1086/527449.
  • Van Damme P, Giaquinto C, Huet F, Gothefors L, Maxwell M, Van der Wielen M. Multicenter Prospective Study of the Burden of Rotavirus Acute Gastroenteritis in Europe, 2004–2005: the REVEAL Study. J Infect Dis. 2007;195(Suppl 1):s4–s16. doi:10.1086/516714.
  • Gambotto S. Il vaccino anti-rotavirus una opportunità per il pediatra di famiglia. Il Giornale della vaccinazione. 2010;Anno II (2):3–6.
  • Ward RL. Possible mechanisms of protection elicited by candidate rotavirus vaccines as determined with the adult mouse model. Viral Immunol. 2003;16(1):17–24. doi:10.1089/088282403763635410.
  • Ward R. Mechanisms of protection against rotavirus infection and disease. Pediatr Infect Dis J. 2009;28(3 Suppl):S57–59. doi:10.1097/INF.0b013e3181967c16.
  • Parashar UD, Cortese MM, Offit PA. Rotavirus Vaccines. Plotkin’s Vaccines. 2018;950-969.e911.
  • European Medicines Agency (EMA). Rotarix - Summary of Product Characteristics. 2020 [ accessed 2020 Oct 09] https://www.ema.europa.eu/en/documents/product-information/rotarix-epar-product-information_en.pdf
  • Bernstein DI. Live Attenuated Human Rotavirus Vaccine, Rotarix™. Semin Pediatr Infect Dis. 2006;17(4):188–94. doi:10.1053/j.spid.2006.08.006.
  • European Medicines Agency (EMA). Rotarix - Scientific discussion. 2006 [ accessed 2020 Oct 09] https://www.ema.europa.eu/en/documents/scientific-discussion/rotarix-epar-scientific-discussion_en.pdf
  • European Medicines Agency (EMA). Rotarix EPAR. 2006 [ accessed 2021 Jan 06] https://www.ema.europa.eu/en/medicines/human/EPAR/rotarix
  • European Medicines Agency (EMA). RotaTeq EPAR. 2006 [ accessed 2021 Jan 06] https://www.ema.europa.eu/en/medicines/human/EPAR/rotateq
  • Burnett E, Parashar U, Tate J. Rotavirus vaccines: effectiveness, safety, and future directions. Paediatr Drugs. 2018;20:223–33. doi:10.1007/s40272-018-0283-3.
  • Martinelli D, Fortunato F, Marchetti F, Prato R. Rotavirus vaccine administration patterns in Italy: potential impact on vaccine coverage, compliance and adherence. Hum Vaccin Immunother. 2020;17(5):1546–51. doi:10.1080/21645515.2020.1816109.
  • Marchetti F, Morelli P. Measuring public health officers‘ opinions on new vaccination programs by means of the WHO Vaccine Introduction Guidelines. Hum Vaccin. 2009;5(9):640–44. doi:10.4161/hv.9092.
  • Cantarutti A, Cantarutti L, Conforti G, Marchetti F, Sciolla N. La percezione dei pediatri di famiglia associati FIMP sulla vaccinazione contro le gastroenteriti acute da rotavirus. Presented at: 70° Congresso Italiano di Pediatria - SIP Palermo 11-14 giugno 2014. Il Medico Pediatra 1. 2014:32–33. [ accessed 2021 Apr 29]. https://www.ilmedicopediatra-rivistafimp.it/wp-content/uploads/2019/03/05_ATTIVITA-PROFESSIONALE_Rotavirus-1.pdf
  • Amodio E, Costantino C, Cracchiolo M, Sciuto V, Vitale F. Health Technology Assessment Rotarix: L’esperienza della Sicilia quale regione capofila nella introduzione della vaccinazione universale contro i rotavirus. Ital J Public Health. 2014;3:28–37.
  • Mita V, Arigliani M, Zaratti L, Arigliani R, Franco E. Italian physicians’ opinions on rotavirus vaccine implementation. Pathogens. 2017;6(4):56. doi:10.3390/pathogens6040056.
  • Diez Domingo J, Patrzalek M, Cantarutti L, Arnould B, Meunier J, Soriano-Gabarro M, Meyer N, Pirçon J-Y, Holl K. The impact of childhood acute rotavirus gastroenteritis on the parents’ quality of life: prospective observational study in European primary care medical practices. BMC Pediatr. 2012;12:58. doi:10.1186/1471-2431-12-58.
  • Marchetti F, Vetter V, Conforti G, Esposito S, Bonanni P. Parents‘ insights after pediatric hospitalization due to rotavirus gastroenteritis in Italy. Hum Vaccin Immunother. 2017;13(9):2155–59. doi:10.1080/21645515.2017.1336271.
  • Napolitano F, Ali Adou A, Vastola A, Angelillo IF. Rotavirus infection and vaccination: knowledge, beliefs, and behaviors among parents in Italy. Int J Environ Res Public Health. 2019;16(10):1807. doi:10.3390/ijerph16101807.
  • Amadori F, Terracciano E, Gennaio I, Mita V, Gargano D, Zaratti L, Franco E, Arigliani R. Opinions and attitudes of Italian healthcare workers towards recommended but not compulsory rotavirus vaccination. Hum Vaccin Immunother. 2021;17(2):497–502. doi:10.1080/21645515.2020.1776546.
  • Marchetti F, Conforti G. Seconda indagine conoscitiva sull’opinione dei pediatri di famiglia italiani in merito alla vaccinazione contro i rotavirus. Presented at: 51 Congresso Nazionale - Societa Italiana di Igiene (SITI) 17-20 ottobre. Riva del Garda, Italy; 2018. p. 225. [accessed 2021 Apr 29]. http://www.igienistionline.it/docs/2018/41abstract.pdf .
  • Societa Italiana di Igiene (SItI), Federazione Italiana Medici Pediatri (FIMP), (FIMMG). FIMdMG. Calendario Vaccinale Per La Vita 2012 [ accessed 2020 Oct 07] https://docplayer.it/4948666-Calendario-vaccinale-per-la-vita.html
  • Societa Italiana di Pediatria (SIP), Societa Italiana di Igiene (SItI), Federazione Italiana Medici Pediatri (FIMP), (FIMMG). FIMdMG. Calendario Vaccinale Per La Vita 2° Edizione 2014 [ accessed 2020 Oct 07] http://www.asl5.liguria.it/Portals/0/Comunicati/19022015_Calendario-per-la-vita-2014-1.pdf
  • Societa Italiana di Pediatria (SIP), Societa Italiana di Igiene (SItI), Federazione Italiana Medici Pediatri (FIMP), (FIMMG). FIMdMG. Calendario Vaccinale Per La Vita 3° Edizione 2016 [ accessed 2020 Oct 07] http://www.apel-pediatri.org/attachments/794_Calendario_vaccini_16.pdf
  • Societa Italiana di Pediatria (SIP), Societa Italiana di Igiene (SItI), Federazione Italiana Medici Pediatri (FIMP), (FIMMG). FIMdMG. Calendario Vaccinale Per La Vita 4° Edizione 2019 [ accessed 2020 Oct 07] http://www.igienistionline.it/docs/2019/21cvplv.pdf
  • Government of Italy. Piano Nazionale Prevenzione Vaccinale: PNPV 2017-2019. 2017 [ accessed 2020 Oct 09] http://www.salute.gov.it/imgs/C_17_pubblicazioni_2571_allegato.pdf
  • Ministero della Salute. Ufficio V – prevenzione delle malattie trasmissibili e profilassi internazionale. 2017 [ accessed 2021 Mar 19] https://www.ordfarmbo.it/multimedia/allegati/10585-all1.PDF
  • Costantino C, Amodio E, Vitale F. Impact on rotavirus gastro-enteritis hospitalisation during the first year of universal vaccination in Sicily. Paediatrics and International Child Health. 2015;35(4):342–43. doi:10.1080/20469047.2015.1109240.
  • Restivo V, Caracci F, Sannasardo CE, Scarpitta F, Vella C, Ventura G, Tramuto F, Costantino C. Rotavirus gastroenteritis hospitalization rates and correlation with rotavirus vaccination coverage in Sicily. Acta Biomed. 2018;89:437–42. doi:10.23750/abm.v89i3.7578.
  • Costantino C, Restivo V, Tramuto F, Casuccio A, Vitale F. Universal rotavirus vaccination program in Sicily: reduction in health burden and cost despite low vaccination coverage. Hum Vaccin Immunother. 2018;14(9):2297–302. doi:10.1080/21645515.2018.1471306.
  • Zuccotti G, Meneghin F, Dilillo D, Romanò L, Bottone R, Mantegazza C, Giacchino R, Besana R, Ricciardi G, Sterpa A, et al. Epidemiological and clinical features of rotavirus among children younger than 5 years of age hospitalized with acute gastroenteritis in Northern Italy. BMC Infect Dis. 2010;10:218. doi:10.1186/1471-2334-10-218.
  • Panatto D, Amicizia D, Giacchino R, Tacchella A, Natalizia AR, Melioli G, B andettini R, Di Pietro P, Diana MC, Gasparini R. Burden of rotavirus infections in Liguria, Northern Italy: hospitalisations and potential savings by vaccination. Eur J Clin Microbiol Infect Dis. 2011;30(8):957–64. doi:10.1007/s10096-011-1180-7.
  • Forster J, Guarino A, Parez N, Moraga F, Román E, Mory O, Tozzi AE, de Aguileta AL, Wahn U, Graham C, et al. Hospital-based surveillance to estimate the burden of rotavirus gastroenteritis among European children younger than 5 years of age. Pediatrics. 2009;123(3):e393–400. doi:10.1542/peds.2008-2088.
  • Albano F, Bruzzese E, Bella A, Cascio A, Titone L, Arista S, Izzi G, Virdis R, Pecco P, Principi N, et al. Rotavirus and not age determines gastroenteritis severity in children: a hospital-based study. Eur J Pediatr. 2007;166(3):241–47. doi:10.1007/s00431-006-0237-6.
  • Diez-Domingo J, Baldo J-M, Patrzalek M, Pazdiora P, Forster J, Cantarutti L, Pirçon J-Y, Soriano-Gabarró M, Meyer N. Primary care-based surveillance to estimate the burden of rotavirus gastroenteritis among children aged less than 5 years in six European countries. Eur J Pediatr. 2011;170(2):213–22. doi:10.1007/s00431-010-1289-1.
  • Amodio E, Tabacchi G, Cracchiolo M, Sciuto V, Vitale F. Hospitalisation of children aged 0–59 months with rotavirus gastro-enteritis before the introduction of routine vaccination (Sicily 2003–2012). Paediatr Int Child Health. 2015;35(4):319–23. doi:10.1080/20469047.2015.1109228.
  • Gabutti G, Lazzara C, Marsella M, Bergamini M, Malaventura C, Borgna-Pignatti C. Burden of hospitalizations due to Rotavirus infection in Emilia Romagna, Italy. Acta Biomed. 2007;78:176–81.
  • Fontana M, Zuin G, Pancheri P, Fusco FC, Lambertini A, Berni Canani R. Costs associated with outpatient diarrhoea in infants and toddlers: a nationwide study of the Italian Society of Paediatric Gastroenterology and Hepatology (SIGEP). Dig Liver Dis. 2004;36(8):523–27. doi:10.1016/j.dld.2004.03.012.
  • Giammanco MD, Coniglio MA, Pignato S, Giammanco G. An economic analysis of rotavirus vaccination in Italy. Vaccine. 2009;27(29):3904–11. doi:10.1016/j.vaccine.2009.04.002.
  • Standaert B, Marocco A, Assael B, Gabutti G, Guarino A, Lopalco PL, Marchetti F, Ruggeri F, Titone L, Tozzi A, et al. [Cost-effectiveness of universal rotavirus vaccination with Rix4414 in Italy]. Pharmacoeconomics-Italian Research Articles. 2008;10(1):23–35. doi:10.1007/BF03320638.
  • Vitale F, Barbieri M, Dirodi B, Vitali Rosati G, Franco E. [A full economic evaluation of extensive vaccination against rotavirus with RIX4414 vaccine at National and Regional level in Italy]. Ann Ig. 2013;25:43–56. doi:10.7416/ai.2013.1905.
  • Capri S, Veneziano MA. Health Technology Assessment Rotarix: la vaccinazione anti-rotavirus in Italia: valutazione economica. QIJPH. 2014;3:55–67.
  • Ministero della Salute. Vaccinazioni dell’età pediatrica. Anno 2019 (coorte 2017). 2019 [ accessed 2021 Jan 26] http://www.salute.gov.it/imgs/C_17_tavole_20_8_1_file.pdf
  • Barbato C, Cattaneo EE. Efficace introduzione della vaccinazione contro i rotavirus nella Regione Lombardia. Il Giornale della vaccinazione. 2018; Anno X:4–6.
  • Aquilani S, Dari S, Fiasca F. Assessing rotavirus vaccination coverage and compliance after two years of local experience in Italy. Ann Ig. 2020;32:433–35. doi:10.7416/ai.2020.2367.
  • Regiona de Veneto. Attività vaccinale 2019: aggiornamento delle coperture vaccinali in età pediatria. 2019 [accessed 2021 Feb 03] http://repository.regione.veneto.it/public/282de3d2c92fff99f414f9496a3cca9d.php?lang=it&dl=true
  • TuttiItalia.it. Andamento demografico della popolazione residente in Veneto dal 2001 al 2019. 2019 [ accessed 2021 Feb 03] https://www.tuttitalia.it/veneto/statistiche/popolazione-andamento-demografico/
  • Regione Piemonte - Direzione Sanità e Welfare - Settore Prevenzione e Veterinaria. Vaccinazioni – recupero attività e aggiornamenti (Classificazione 14.130.30;1/2014C;4). 2014.
  • Bonanni P, Signorelli C. [Anti-rotavirus and intussusception: no evidence to discontinue the universal vaccination policy]. Ig Sanita Pubbl. 2015;71:549–57.
  • Mattei A, Fiasca F, Mazzei M, Sbarbati M. Unparalleled patterns of intussusception and rotavirus gastroenteritis hospitalization rates among children younger than six years in Italy. Ann Ig. 2017;29:38–45. doi:10.7416/ai.2017.2130.
  • Restivo V, Costantino C, Tramuto F, Vitale F. Hospitalization rates for intussusception in children aged 0–59 months from 2009 to 2014 in Italy. Hum Vaccin Immunother. 2017;13(2):445–49. doi:10.1080/21645515.2017.1264784.
  • Costantino C, Restivo V, Cuccia M, Furnari R, Amodio E, Vitale F. Analysis of hospitalizations due to intussusception in Sicily in the pre-rotavirus vaccination era (2003–2012). Ital J Pediat. 2015;41:52. doi:10.1186/s13052-015-0160-4.
  • Trotta F, Da Cas R, Bella A, Santuccio C, Salmaso S. Intussusception hospitalizations incidence in the pediatric population in Italy: a nationwide cross-sectional study. Ital J Pediatr. 2016;42(1):89. doi:10.1186/s13052-016-0298-8.
  • Haber P, Parashar UD, Haber M, DeStefano F. Intussusception after monovalent rotavirus vaccine—United States, Vaccine Adverse Event Reporting System (VAERS), 2008–2014. Vaccine. 2015;33(38):4873–77. doi:10.1016/j.vaccine.2015.07.054.
  • Agenzia Italiana del Farmaco (AIFA). Comunicazione di sicurezza sui vaccini anti-rotavirus. 2017 [ accessed 2020 Oct 09] http://www.crfvcalabria.it/doc/Comunicazione_sicurezza_rotavirus_rev_22_05.pdf
  • McGeoch LJ, Finn A, Marlow RD. Impact of rotavirus vaccination on intussusception hospital admissions in England. Vaccine. 2020;38(35):5618–26. doi:10.1016/j.vaccine.2020.06.078.
  • Bianconi M, Adorni V, Nucci A, Ghiori F, Ricci S, Nieddu F, Lippi F. 558 - Gestione clinica di casi di invaginazione intestinale presso l’ospedale meyer negli anni 2009-2013 in bambini vaccinati o meno contro i rotavirus. Presented at: 48 Congresso Societa Italiana di Igiene (SItI) 14 – 17 Ottobre. Milan: Italy; 2015, p. 167. [accessed 2021 Apr 29]. http://www.sitinazionale.org/site/new/images/docs/congressi/2015/1014milanoatti.pdf .
  • Costantino C, Restivo V, Tramuto F, Casuccio A, Palermo M, Vitale F. Safety of in-neonatal intensive care unit administration of rotavirus vaccination among preterms. European Journal of Public Health. 2020;32(1):167-91. doi:10.1093/eurpub/ckaa165.1255.
  • Agenzia Italiana del Farmaco (AIFA). Comunicazione di sicurezza sui vaccini anti-rotavirus. 2017 [ accessed 2020 Oct 09] http://www.crfvcalabria.it/doc/Comunicazione_sicurezza_rotavirus_rev_22_05.pdf
  • Agenzia Italiana del Farmaco (AIFA). Rapporto Vaccini 2018 - la sorveglianza postmarketing in Italia. 2018 [ accessed 2020 Oct 09] https://www.aifa.gov.it/documents/20142/241056/Rapporto+Vaccini+2018.pdf/62975a0e-a836-da32-f7b9-1e39196374dd
  • Agenzia Italiana del Farmaco (AIFA). Rapporto Vaccini 2019 - la sorveglianza postmarketing in Italia. 2019 [ accessed 2021 Jan 18] https://www.aifa.gov.it/documents/20142/241052/Rapporto_Vaccini_2019.pdf/78c5e8ef-938d-add8-52b2-869e6dab323f
  • Willame C, Cheuvart B, Aris E, Vetter V, Cohet C. Association between rotavirus gastroenteritis and intussusception: suggested evidence from a retrospective study in claims databases in the United States. Hum Vaccin Immunother. 2021;17(1):269–77. doi:10.1080/21645515.2020.1770514.
  • Restivo V, Costantino C, Giorgianni G, Cuccia M, Tramuto F, Corsello G, Casuccio A, Vitale F. Case–control study on intestinal intussusception: implications for anti-rotavirus vaccination. Expert Rev Vaccines. 2018;17(12):1135–41. doi:10.1080/14760584.2018.1546122.
  • Mansour AM, El Koutby M, El Barbary MM, Mohamed W, Shehata S, El Mohammady H, Mostafa M, Riddle MS, Sebeny PJ, Young SY, et al. Enteric viral infections as potential risk factors for intussusception. J Infect Dev Ctries. 2013;7(1):28–35. doi:10.3855/jidc.2321.
  • Minney-Smith CA, Levy A, Hodge M, Jacoby P, Williams SH, Carcione D, Roczo-Farkas S, Kirkwood CD, Smith DW. Intussusception is associated with the detection of adenovirus C, enterovirus B and rotavirus in a rotavirus vaccinated population. J Clin Virol. 2014;61(4):579–84. doi:10.1016/j.jcv.2014.10.018.
  • Paulke-Korinek M, Kundi M, Rendi-Wagner P, De Martin A, Eder G, Schmidle-Loss B, Vecsei A, Kollaritsch H. Herd immunity after two years of the universal mass vaccination program against rotavirus gastroenteritis in Austria. Vaccine. 2011;29(15):2791–96. doi:10.1016/j.vaccine.2011.01.104.
  • European Centre for Disease Prevention and Control (ECDC). Scientific Advice - Expert opinion on rotavirus vaccination in infancy. 2017 [ accessed 2020 Oct 12]. https://www.ecdc.europa.eu/en/publications-data/expert-opinion-rotavirus-vaccination-infancy
  • Gómez-Rial J, Rivero-Calle I, Salas A, Martinón-Torres F. Rotavirus and autoimmunity. J Infect. 2020;81(2):183–89. doi:10.1016/j.jinf.2020.04.041.
  • Rivero-Calle I, Gómez-Rial J, Martinón-Torres F. Systemic features of rotavirus infection. J Infect. 2016;72(Suppl):s98–s105. doi:10.1016/j.jinf.2016.04.029.
  • Pringle KD, Burke RM, Steiner CA, Parashar UD, Tate JE. Trends in rate of seizure-associated hospitalizations among children <5 years old before and after rotavirus vaccine introduction in the United Sates, 2000-2013. J Infect Dis. 2018;217:581–88. doi:10.1093/infdis/jix589.
  • Perrett KP, Jachno K, Nolan TM, Harrison LC. Association of rotavirus vaccination with the incidence of type 1 diabetes in children. JAMA Pediatrics. 2019;173(3):280–82. doi:10.1001/jamapediatrics.2018.4578.
  • Rogers MAM, Basu T, Kim C. Lower incidence rate of type 1 diabetes after receipt of the rotavirus vaccine in the United States, 2001–2017. Sci Rep. 2019;9(1):7727. doi:10.1038/s41598-019-44193-4.